Top entities: India, India — Drugs Technical Advisory Board, Asian Coalition for Health Empowerment, India — Economic Advisory Council to the Prime Minister, World Health Organization.

What category does this event fall under?

Regulatory — classified as policy recommendation.

What is the sentiment of coverage?

Aggregate sentiment score: 30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

India — Economic Advisory Council to the Prime Minister published report · Asian Coalition for Health Empowerment organized event

Is this event still developing?

This is an active story, last updated May 08, 2026. Coverage continues to evolve.

Regulatory policy recommendation

India OTC Nicotine Therapy Access

Q: When did this event occur?

First reported May 07, 2026; last updated May 08, 2026.

Q: What is the market impact?

Direct. The recommendation to keep nicotine replacement therapies (NRTs) over-the-counter in India could positively impact pharmaceutical companies producing these products by ensuring continued market access.

Analysis based on 9 articles · First reported May 07, 2026 · Last updated May 08, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The recommendation to keep nicotine replacement therapies (NRTs) over-the-counter in India could positively impact pharmaceutical companies producing these products by ensuring continued market access. Conversely, it could indirectly affect tobacco companies if it leads to a significant reduction in tobacco consumption in India, as highlighted by the India — Economic Advisory Council to the Prime Minister's report.

Pharmaceuticals Healthcare Tobacco

Event Summary

Public health experts in India are urging the India — Drugs Technical Advisory Board to maintain over-the-counter access for 2 mg and 4 mg nicotine replacement therapies (NRTs). This recommendation, made at the Respire-2026 event organized by the Asian Coalition for Health Empowerment, aims to strengthen tobacco cessation pathways in India, where quit success rates are currently below 5%. The discussion is informed by a report from the India — Economic Advisory Council to the Prime Minister, which emphasizes the economic burden of tobacco use and the benefits of reducing consumption. Experts, including Dr. Karl Fagerstrom, noted that the World Health Organization lists these NRT doses as essential medicines, and many OECD countries already offer them over-the-counter. The goal is to ensure these cessation tools are readily available to help India's 267 million tobacco users.

Key Actions

60 India — Economic Advisory Council to the Prime Minister published report

50 Asian Coalition for Health Empowerment organized event

Entities Involved

cnt

India

India faces a significant tobacco burden and low quit rates, making the accessibility of nicotine replacement therapies crucial for public health and economic welfare.

Importance 90 Sentiment 30

govactor

India — Drugs Technical Advisory Board

The India — Drugs Technical Advisory Board is urged by public health experts to maintain over-the-counter access for 2 mg and 4 mg nicotine replacement therapies.

Importance 80 Sentiment 20

ngo

Asian Coalition for Health Empowerment

The Asian Coalition for Health Empowerment organized Respire-2026, an event where experts discussed strengthening tobacco cessation pathways.

Importance 70 Sentiment 20

govactor

India — Economic Advisory Council to the Prime Minister

The India — Economic Advisory Council to the Prime Minister's report highlights the economic burden of tobacco use and the potential for improved household welfare through reduced consumption.

Importance 60 Sentiment 10

ngo

World Health Organization

The World Health Organization lists 2 mg and 4 mg doses of nicotine replacement therapies as essential medicines.

Importance 40 Sentiment 10

alliance

OECD

The majority of OECD countries make 2 mg and 4 mg doses of nicotine replacement therapies available over-the-counter.

Importance 40 Sentiment 10

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard